Vaccination

FDA advisers weigh COVID-19 booster shots for fall

Outlining a daunting timeline for development of any updated COVID-19 vaccine for next fall, federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin ...

Oncology & Cancer

NICE says 'not enough data' to approve drug for ovarian cancer

The National Institute for Health and Care Excellence (NICE) says it cannot give a positive decision over whether to recommend a new drug for ovarian cancer unless its makers provide more information on cost. A final decision ...

Medications

Fearing abuse, US blocks generic OxyContin (Update)

U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.

Medications

Renaissance in new drugs for rare diseases

Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, who are ...

Diseases, Conditions, Syndromes

US tainted drug outbreak rises to 185 cases

The number of people believed to have been sickened by a contaminated drug rose to 185 Friday, but US health officials said the death toll from the rare meningitis outbreak held steady at 14.

page 5 from 20